Expression of β-1,4-galactosyltransferase and suppression of β- N-acetylglucosaminidase to aid synthesis of complex N-glycans in insect Drosophila S2 cells

Previously, we have shown that simple paucimannosidic N-glycan structures in insect Drosophila S2 cells arise mainly because of β- N-acetylglucosaminidase (GlcNAcase) action. Thus, in an earlier report, we suppressed GlcNAcase activity and clearly demonstrated that more complex N-glycans with two te...

Full description

Saved in:
Bibliographic Details
Published inJournal of biotechnology Vol. 153; no. 3; pp. 145 - 152
Main Authors Kim, Yeon Kyu, Kim, Kyoung Ro, Kang, Dong Gyun, Jang, So Young, Kim, Young Hwan, Cha, Hyung Joon
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier B.V 20.05.2011
Elsevier
Subjects
Sia
Gal
Fuc
Man
Glc
Online AccessGet full text

Cover

Loading…
More Information
Summary:Previously, we have shown that simple paucimannosidic N-glycan structures in insect Drosophila S2 cells arise mainly because of β- N-acetylglucosaminidase (GlcNAcase) action. Thus, in an earlier report, we suppressed GlcNAcase activity and clearly demonstrated that more complex N-glycans with two terminal N-acetylglucosamine (GlcNAc) residues were then synthesized. In the present work, we investigated the synergistic effects of β-1,4-galactosyltransferase (GalT) expression and GlcNAcase suppression on N-glycan patterns. We found that the N-glycan pattern of human erythropoietin secreted by engineered S2 cells expressing GalT but not GlcNAcase was complete, even in small portion, except for sialylation; the N-glycan structures had two terminal galactose (Gal) residues. When GalT was expressed but GlcNAcase was not inhibited, N-glycan with GlcNAc and Gal at only one branch end was synthesized. Therefore, it will be possible to express a complete functional human glycoprotein in engineered Drosophila S2 cells by suppressing GlcNAcase and co-expressing additional glycosyltransferases of N-glycosylation pathway.
Bibliography:http://dx.doi.org/10.1016/j.jbiotec.2011.03.021
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0168-1656
1873-4863
DOI:10.1016/j.jbiotec.2011.03.021